NovoCure
NVCR
NVCR
235 hedge funds and large institutions have $1.59B invested in NovoCure in 2024 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 45
0% less funds holding
Funds holding: 236 → 235 (-1)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
235
Holding in Top 10
2
Calls
$22.4M
Puts
$5.55M
Top Buyers
| 1 | +$52.2M | |
| 2 | +$48.5M | |
| 3 | +$29.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.9M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.5M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$12.1M | |
| 3 | -$10.1M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$9.59M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$8.01M |